1-156041559-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_020131.5(UBQLN4):āc.1579A>Gā(p.Thr527Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000806 in 1,613,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_020131.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBQLN4 | NM_020131.5 | c.1579A>G | p.Thr527Ala | missense_variant | 10/11 | ENST00000368309.4 | NP_064516.2 | |
UBQLN4 | NM_001304342.2 | c.1519A>G | p.Thr507Ala | missense_variant | 10/11 | NP_001291271.1 | ||
UBQLN4 | XM_024448469.2 | c.1579A>G | p.Thr527Ala | missense_variant | 10/11 | XP_024304237.1 | ||
UBQLN4 | XM_047425666.1 | c.1045A>G | p.Thr349Ala | missense_variant | 10/11 | XP_047281622.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBQLN4 | ENST00000368309.4 | c.1579A>G | p.Thr527Ala | missense_variant | 10/11 | 1 | NM_020131.5 | ENSP00000357292 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250486Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135396
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1460894Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 726776
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at